BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8077048)

  • 1. Transcriptional activation of the urokinase receptor gene in invasive colon cancer.
    Wang H; Skibber J; Juarez J; Boyd D
    Int J Cancer; 1994 Sep; 58(5):650-7. PubMed ID: 8077048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
    Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
    Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines.
    Hollas W; Hoosein N; Chung LW; Mazar A; Henkin J; Kariko K; Barnathan ES; Boyd D
    Thromb Haemost; 1992 Dec; 68(6):662-6. PubMed ID: 1337629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity.
    Clayman G; Wang SW; Nicolson GL; el-Naggar A; Mazar A; Henkin J; Blasi F; Goepfert H; Boyd DD
    Int J Cancer; 1993 Apr; 54(1):73-80. PubMed ID: 8386710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display.
    Schlechte W; Brattain M; Boyd D
    Cancer Commun; 1990; 2(5):173-9. PubMed ID: 2164413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
    Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
    Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
    Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
    Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line.
    Hollas W; Soravia E; Mazar A; Henkin J; Blasi F; Boyd D
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):629-34. PubMed ID: 1322138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynold LM
    Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer.
    Hollas W; Blasi F; Boyd D
    Cancer Res; 1991 Jul; 51(14):3690-5. PubMed ID: 1648443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
    Antalis TM; Reeder JA
    Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
    Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
    Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
    Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
    J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of an SRC kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness.
    Boyd DD; Wang H; Avila H; Parikh NU; Kessler H; Magdolen V; Gallick GE
    Clin Cancer Res; 2004 Feb; 10(4):1545-55. PubMed ID: 14977859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells.
    Dang J; Wang Y; Doe WF
    FEBS Lett; 1995 Feb; 359(2-3):147-50. PubMed ID: 7867787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis.
    Allgayer H; Wang H; Shirasawa S; Sasazuki T; Boyd D
    Br J Cancer; 1999 Aug; 80(12):1884-91. PubMed ID: 10471035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
    McGarvey TW; Kariko K; Barnathan ES; Thomas J; Malkowicz SB
    Int J Oncol; 1998 Jan; 12(1):175-80. PubMed ID: 9454902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular regulation of urokinase-receptor gene expression as one potential concept for molecular staging and therapy.
    Allgayer H
    Recent Results Cancer Res; 2003; 162():15-30. PubMed ID: 12790318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.